fastest

11
# 1 Laboratory for Fatty Acid analysis Fatty Acid www.fastest.it

Upload: davide-cilano

Post on 30-Jul-2015

28 views

Category:

Health & Medicine


2 download

TRANSCRIPT

# 1

“ Laboratory for Fatty Acid analysis “

Fatty Acid

♥ www.fastest.it

# 21. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary

FAsTEST has devised a new method for analysis of fatty acids (including Omega3), which allows reducing the time and cost compared to other FA analysis.

Customers are Medical brokers, Laboratories, Pharma and Wellness Companies

Company highlightsCompany highlights

Heal t h and Psychol ogical S t at us

Diet and L if eS t yl e

Fat t y Acids l evel s in bl ood

# 31. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary

Products & services overviewProducts & services overview

Fatty Acid Test in the blood

Studies and research for companies / entities

Partnership

Pro

du

cts

Ser

vice

s

Pro

du

cts

Ser

vice

s

The activities do not have environmental impacts.

Use of non-toxic gas.

Limited energy

# 41. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary

Market overview and market entryMarket overview and market entry

StudiesFatty Acid Test

Collaboration Contracts

• Research Institutions and Companies interested in studies with the aim of aligning products to customer needs

• Medical-Scientific Brokers such as pharmacies, health centers, health care facilities, laboratories, medical specialists who are interested in the performance and applications in care prevention.

• Company Py-Intensive where it is essential physical and mental readiness for the conduct of business. Examples are sports clubs in general, activities with high responsibilities like public transport, airlines, military.

Research Institutions and CompaniesBrokers Medical-Scientific

Company Py-Intensive

Population:

World 6.790 mlnEurope EU 495 mln United States 307 mlnItaly 58 mlnBenelux 28 mlnPoland 38 mln(July 2009 est.) Source CIA World Factbook

65 mln people TARGET

1.200 Research Institutions and Companies50.000 Brokers and Practitioners500 Py-Intensive Companies

# 51. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary

Partners and collaboratorsPartners and collaboratorsAddresses Headquarters - Viale Tunisia, 38 - 20124 Milano

Funding Received

2006 Winner of Match Compteneze2007 Imprese Creative2009 Bank Financing2009 Startup at Parco tecnologico Padano – Lodi2009 Selected for “Italian Business Angels - Early Stage”

SomeStudies...

Study about the effects of moderate amounts of dairy products with Omega3

Study of different oils and their use in the preparation of bakery

Effects of their horse meat on circulating levels of omega 3 fatty acids in healthy individuals

Levels of Omega 3 in the blood and neurodegenerative diseases

Omega 3 and PND

Levels of DHA during pregnancy

Profiles in AG in malnourished child population in Cambodia

Effects of supplementation with DHA in children with cystic fibrosis

Effects of cigarette smoking during pregnancy

Fatty acids as indicators of risk of stroke and cardiovascular disease

Dental disorders and fatty acids

AG in the elderly population in relation to Alzheimer's...

Partners Under finalisation a commercial agreement for benelux territories

We are looking for partners interested in money, competence and

relations with target customers

# 61. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary

CompetitionCompetition

Competition and Competitive AdvantageCompetitors: Italy and abroad small companies doing analysis of the AG with different methodologies

Lower prices methodologies are not rigorous Higher prices are not justified FASTEST is a reference for many competitors

EntrantsTo reach customers there are high barriers to entry to the sales channelsThe execution of studies require scientific accreditation that is the result of years of work

SuppliersEquipment and Supplies do not have

critical supply

SynergiesFoods and supplements with Omega3

Low analysis price

Team Skills and capabilities

Fatty Acid database with optimum levels

Ability to Innovate and Implement

Need Investment

Need to overcome the barriers to enter into the market

Barriers to entry into the sales channels (pharmacies, care centers, hospitals, ...)

In the case of several attractive market competitors may arise

Good time for the services offered

Available Technology and materials

Advantage over competitors

Weaknesses

Opportunities Threats

Strengths

# 71. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary

Barriers to entryBarriers to entry

Fo

od

-Fu

nct

ion

al F

oo

d

FAsTEST: Competence in Fatty Acids Analysis+

Network for Healthcare promotion and disease prevention =

Fatty Acid analysis for driving food balance for Wellness

Scientific Findings

PreventionWellness

PreventionWellness

Needs

# 81. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary

Management teamManagement team

Claudio Galli – Partner – Scientific Management, R & D Laboratory Manager

Degree in Medicine and Surgery, Professor at the Faculty of Pharmacy, Univ Milan. He has published over 200 scientific articles. In the past, President of the International Society for the Study of Fatty Acids and Lipids (ISSFAL), Director of the Center for Pharmacoeconomics, Director of School of Toxicology.

Franca Marangoni - Director and Partner – Marketing, Sales

Degree in Chemistry and Technology Pharmacology - PhD. Doctor of research in food toxicology. Scientific

coordinator N.F.I. (Nutrition Fundation International). Franca has performed studies for Danone, Novartis, Parmalat on innovative food products with Omega3.

Davide Cilano – Director and Partner – Administration, Finance, Information Technology

Degree in Computer Science with MBA and experience in project management and Business process reingeneering in many industry sectors (Finance, Multimedia, Consumer goods, Pharma).

# 91. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary

Financial projections and Investment opportunityFinancial projections and Investment opportunityBelgium, Netherlands, Luxembourg, Poland

BEP

FAsTEST

Commission 30%

I° Profit m. 45%II° Profit m.25%

Public Institutions and Companies.

People

I° Profit m. 75%II ° Profit m.25%

Company Py-Intensive

Brokers Medical-Scientific

Financials Removed on Public version

# 101. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary

Use of funds and Exit strategyUse of funds and Exit strategy

Financials Removed on Public version

# 111. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary

Resources needed beyond capitalResources needed beyond capital

♥ www.fastest.it

“ Laboratory for Fatty Acid analysis and research “Needs:

Partnership for products and services promotion andMarketing plan competences